Mannkind (MNKD) Total Current Liabilities (2010 - 2026)
Mannkind (MNKD) reported Total Current Liabilities of $134.6 million for Q1 2026, up 16.06% year-over-year from $115.9 million in Q1 2025, and down 21.32% on a QoQ basis from $171.0 million in Q4 2025.
Mannkind (MNKD) has 17 years of Total Current Liabilities data on file, last reported at $134.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 16.06% year-over-year to $134.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.6 million (up 16.06% YoY) and the FY2025 annual result came in at $171.0 million, up 108.99% from the prior year.
- Total Current Liabilities eased to $134.6 million in Q1 2026 per MNKD's latest filing, from $171.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $171.0 million in Q4 2025 and bottomed at $53.5 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $96.4 million (2023), against an average of $93.9 million.
- The widest annual swing landed in 2022, when Total Current Liabilities decreased 26.84%; it then surged 108.99% in 2025.
- Tracing MNKD's Total Current Liabilities over 5 years: stood at $67.3 million in 2022, then soared by 54.73% to $104.1 million in 2023, then fell by 21.41% to $81.8 million in 2024, then jumped by 108.99% to $171.0 million in 2025, then retreated by 21.32% to $134.6 million in 2026.
- Per Business Quant, the three latest MNKD Total Current Liabilities figures stand at $134.6 million (Q1 2026), $171.0 million (Q4 2025), and $109.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 134.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.56 Mn |
| Dec 31, 2025 | 171.03 Mn |
| Sep 30, 2025 | 109.13 Mn |
| Jun 30, 2025 | 111.83 Mn |
| Mar 31, 2025 | 115.94 Mn |
| Dec 31, 2024 | 81.84 Mn |
| Sep 30, 2024 | 72.10 Mn |
| Jun 30, 2024 | 80.01 Mn |
| Mar 31, 2024 | 99.90 Mn |
| Dec 31, 2023 | 104.13 Mn |
| Sep 30, 2023 | 96.37 Mn |
| Jun 30, 2023 | 96.97 Mn |
| Mar 31, 2023 | 81.85 Mn |
| Dec 31, 2022 | 67.30 Mn |
| Sep 30, 2022 | 59.60 Mn |
| Jun 30, 2022 | 59.56 Mn |
| Mar 31, 2022 | 53.49 Mn |
| Dec 31, 2021 | 48.35 Mn |
| Sep 30, 2021 | 50.03 Mn |
| Jun 30, 2021 | 60.43 Mn |
| Mar 31, 2021 | 73.12 Mn |
| Dec 31, 2020 | 73.71 Mn |
| Sep 30, 2020 | 106.12 Mn |
| Jun 30, 2020 | 67.94 Mn |
| Mar 31, 2020 | 68.25 Mn |
| Dec 31, 2019 | 65.62 Mn |
| Sep 30, 2019 | 64.29 Mn |
| Jun 30, 2019 | 76.98 Mn |
| Mar 31, 2019 | 77.87 Mn |
| Dec 31, 2018 | 75.24 Mn |
| Sep 30, 2018 | 59.63 Mn |
| Jun 30, 2018 | 74.90 Mn |
| Mar 31, 2018 | 80.67 Mn |
| Dec 31, 2017 | 87.60 Mn |
| Sep 30, 2017 | 91.47 Mn |
| Jun 30, 2017 | 85.87 Mn |
| Mar 31, 2017 | 93.05 Mn |
| Dec 31, 2016 | 92.05 Mn |
| Sep 30, 2016 | 105.83 Mn |
| Jun 30, 2016 | 289.71 Mn |
| Mar 31, 2016 | 249.21 Mn |
| Dec 31, 2015 | 268.32 Mn |
| Sep 30, 2015 | 267.31 Mn |
| Jun 30, 2015 | 342.25 Mn |
| Mar 31, 2015 | 380.75 Mn |
| Dec 31, 2014 | 403.35 Mn |
| Sep 30, 2014 | 293.78 Mn |
| Jun 30, 2014 | 119.23 Mn |
| Mar 31, 2014 | 44.52 Mn |
| Dec 31, 2013 | 127.79 Mn |
| Sep 30, 2013 | 217.17 Mn |
| Jun 30, 2013 | 266.78 Mn |
| Mar 31, 2013 | 264.21 Mn |
| Dec 31, 2012 | 144.78 Mn |
| Sep 30, 2012 | 51.76 Mn |
| Jun 30, 2012 | 55.44 Mn |
| Mar 31, 2012 | 34.41 Mn |
| Dec 31, 2011 | 25.36 Mn |
| Sep 30, 2011 | 17.31 Mn |
| Jun 30, 2011 | 21.56 Mn |
| Dec 31, 2010 | 18.13 Mn |